HIVに感染した患者でフルコナゾールによるクリプトコックスの髄膜炎の初次予防
V J Quagliarello1, C Viscoli, R I Horwitz
1Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.
Lancet (London, England)
|March 4, 1995
まとめ
口服フルコナゾールは,低CD4カウントのHIV感染患者において,クリプトコック性髄膜炎の最初のエピソードのリスクを大幅に軽減します. この抗真菌薬は,この深刻な好機性感染症に対して実質的な保護を提供します.
科学分野:
- 感染症 感染症は感染症です.
- HIV/AIDSに関する研究 HIV/AIDSに関する研究
- 菌類学 菌類学とは
背景:
- クリプトコック性髄膜炎は,HIV感染者,特にCD4細胞数が250/microL未満の個体において,生命を脅かす機会性感染症である.
- 機会性感染症に対する予防は,HIV/AIDS患者の管理において極めて重要です.
研究 の 目的:
- HIVに感染した患者の間でクリプトコック性髄膜炎の初期発生を防ぐために,口服用フルコナゾールの有効性を調査する.
- フルコナゾール曝露が,脆弱なHIV陽性集団における暗号球菌性髄膜炎のリスクの低下と関連しているかどうかを判断する.
主な方法:
- 症例対照試験は,CD4カウント<250/microLのHIV感染患者を対象に実施されました.
- 症例はクリプトコック性髄膜炎を発症した患者であり,対照群は脳脊髄液クリプトコック性検査で陰性であり,人口統計学的および臨床的要因でマッチングされた.
- 診断前の6ヶ月間のフルコナゾールへの経口暴露を評価した.
主要な成果:
- コントロール群 (36%) と比べて,症例の有意に低い割合 (11%) が,経口フクロコナゾールを投与されていた.
- フルコナゾルの暴露は,暗号球菌性髄膜炎を発症するリスクの92%の減少と関連していました (マッチした確率比 = 0.08,p = 0.035).
- 症例と対照群のベースラインの特徴において,フルコナゾール曝露を除いて,有意な差異は観察されなかった.
結論:
- 口服フルコナゾールは,CD4カウント<250/microLのHIV感染患者におけるクリプトコック性髄膜炎の最初のエピソードに対する有意な保護効果を示しています.
- 最適な投与量は決定されていませんが,研究結果は,フルコナゾールの非日常的な使用が予防に有効であることを示唆しています.
- これらの結果は,この患者群において,クリプトコック性髄膜炎に対するプライマリ予防のためにフルコナゾールを考慮することを支持しています.
関連する概念動画
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


